Latest debt-to-equity ratio
Caris Life Sciences Debt-to-equity ratio
Direct answer
Caris Life Sciences's debt-to-equity ratio is 76.45%.
The verified market snapshot reports 76.45%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Caris Life Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 76.45%
Explore related company data
View Caris Life Sciences's market capitalizationView Caris Life Sciences's p/e ratioView Caris Life Sciences's price-to-book ratioView Caris Life Sciences's return on equityView Caris Life Sciences's dividend yieldView Caris Life Sciences's 52-week price rangeView Caris Life Sciences's revenue growthView Caris Life Sciences's profit marginView all Caris Life Sciences key metricsReturn to Caris Life Sciences profile